Skip to main content

Understanding asthma phenotypes: going beyond the atopic/non-atopic paradigm

Objective

Fifteen years ago it was widely believed that asthma was an allergic/atopic disease caused by allergen exposure in infancy; this produced atopic sensitization and continued exposure resulted in eosinophilic airways inflammation, bronchial hyper-responsiveness and reversible airflow obstruction. It is now clear that this model is at best incomplete. Less than one-half of asthma cases involve allergic (atopic) mechanisms, and most asthma in low-and-middle income countries is non-atopic. Westernization may be contributing to the global increases in asthma prevalence, but this process appears to involve changes in asthma susceptibility rather than increased exposure to “established” asthma risk factors. Understanding why these changes are occurring is essential in order to halt the growing global asthma epidemic.This will require a combination of epidemiological, clinical and basic science studies in a variety of environments.

A key task is to reclassify asthma phenotypes. These are important to: (i) better understand the aetiological mechanisms of asthma; (ii) identify new causes; and (iii) identify new therapeutic measures. There are major opportunities to address these issues using new techniques for sample collection from the airways (sputum induction, nasal lavage), new methods of analysis (microbiome, epigenetics), and new bioinformatics methods for integrating data from multiple sources and levels. There is an unprecedented potential to go beyond the old atopic/non-atopic categorization of phenotypes.

I will therefore conduct analyses to re-examine and reclassify asthma phenotypes. The key features are the inclusion of: (i) both high and low prevalence centres from both high income countries and low-and-middle income countries; (ii) much more detailed biomarker information than has been used for previous studies of asthma phenotypes; and (iii) new bioinformatics methods for integrating data from multiple sources and levels.

Host institution

LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER
Net EU contribution
€ 1 067 832,00
Address
Keppel Street
WC1E 7HT London
United Kingdom

See on map

Region
London Inner London — West Camden and City of London
Activity type
Higher or Secondary Education Establishments
Non-EU contribution
€ 0,00

Beneficiaries (6)

LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER
United Kingdom
Net EU contribution
€ 1 067 832,00
Address
Keppel Street
WC1E 7HT London

See on map

Region
London Inner London — West Camden and City of London
Activity type
Higher or Secondary Education Establishments
Non-EU contribution
€ 0,00
UNIVERSIDADE FEDERAL DA BAHIA
Brazil
Net EU contribution
€ 255 882,00
Address
Rua Augusto Vianna Sn Canela
40110-060 Salvador

See on map

Activity type
Higher or Secondary Education Establishments
Non-EU contribution
€ 0,00
UNIVERSITY OF BRISTOL
United Kingdom
Net EU contribution
€ 269 141,00
Address
Beacon House Queens Road
BS8 1QU Bristol

See on map

Region
South West (England) Gloucestershire, Wiltshire and Bristol/Bath area Bristol, City of
Activity type
Higher or Secondary Education Establishments
Non-EU contribution
€ 0,00
ST GEORGE'S HOSPITAL MEDICAL SCHOOL
United Kingdom
Net EU contribution
€ 255 880,00
Address
Cranmer Terrace
SW17 0RE London

See on map

Region
London Inner London — West Wandsworth
Activity type
Higher or Secondary Education Establishments
Non-EU contribution
€ 0,00
UNITED KINGDOM RESEARCH AND INNOVATION

Participation ended

United Kingdom
Net EU contribution
€ 30 093,00
Address
Polaris House North Star Avenue
SN2 1FL Swindon

See on map

Region
South West (England) Gloucestershire, Wiltshire and Bristol/Bath area Swindon
Activity type
Research Organisations
Non-EU contribution
€ 0,00
MASSEY UNIVERSITY
New Zealand
Net EU contribution
€ 469 975,00
Address
Tennent Drive
4442 Palmerston North

See on map

Activity type
Higher or Secondary Education Establishments
Non-EU contribution
€ 0,00